Bain Capital Specialty Finance, Inc. (BCSF) Cash Flow Statement
Where BCSF’s cash came from and went, 2025
December 31, 2025 · U.S. dollars- Cash from operations
- $29.5M −73.8% vs 2024
- Capital expenditures
- $0 0.0% of revenue
- Free cash flow
- $29.5M 12.3% margin
- Returned to shareholders
- $145.8M 494% of free cash flow
- Change in cash
- −$40.2M cash at year-end $58.9M
Drawn to scale: where the cash came from and how it was used. Hover for values.
BCSF operating cash flow, capex and free cash flow
BCSF cash flow trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$100.8M2016 | $29.5M2025 | — | |
| Capital expenditures | $02016 | $02025 | — | |
| Free cash flow | −$100.8M2016 | $29.5M2025 | — | |
| Free cash flow margin | −4,760.7%2016 | 12.3%2025 | +4,773.0 pts | |
| Operating cash flow / net income | −165.472016 | 0.302025 | +165.77 | |
| Dividends paid | $7.8M2016 | $145.8M2025 | +38.5%/yr | |
| Share buybacks (net) | $02016 | $02019 | — | |
| Capex / revenue | 0.0%2016 | 0.0%2025 | 0.0 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BCSF cash flow by activity
BCSF net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
BCSF cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | $98.8M | $119.4M | $123.4M | $105.5M | $119.8M | $8.3M | $98.1M | $26.6M | $19.3M | $608,975 |
| Depreciation & amortization | $5.2M | −$1.1M | −$1.8M | $325,000 | −$33.6M | $16.5M | $110 | −$14.6M | $329,995 | $91,152 |
| Change in working capital | $12.8M | $2.9M | $9.3M | −$8.4M | −$9.5M | −$13.1M | $9.0M | $486,000 | −$4.1M | $221,002 |
| Other non-cash items | −$87.2M | −$8.6M | −$5.0M | −$414.3M | $188.9M | $77.8M | −$349.8M | −$786.8M | −$712.9M | −$101.7M |
| Cash from operating activities | $29.5M | $112.6M | $125.9M | −$316.8M | $265.6M | $89.4M | −$242.8M | −$774.2M | −$697.4M | −$100.8M |
| Investing activities | ||||||||||
| Capital expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions & other investing | −$97.2M | −$139.7M | $93.4M | −$431.0M | $211.1M | $13.5M | −$344.6M | −$828.2M | −$708.1M | −$100.0M |
| Cash from investing activities | −$97.2M | −$139.7M | $93.4M | −$431.0M | $211.1M | $13.5M | −$344.6M | −$828.2M | −$708.1M | −$100.0M |
| Financing activities | ||||||||||
| Dividends paid | −$145.8M | −$114.3M | −$99.4M | −$87.8M | −$87.8M | −$86.3M | −$81.2M | −$41.0M | −$7.8M | −$7.8M |
| Share repurchases & issuance (net) | — | — | — | — | — | — | $1.8M | $524.3M | $392.7M | $109.8M |
| Net borrowing (repayment) | $77.8M | $131.7M | −$132.0M | $330.5M | −$36.8M | −$113.5M | $364.5M | $186.0M | $391.3M | $59.1M |
| Shares issued | $5.5M | $0 | $0 | $0 | $0 | $131.9M | $131.9M | $524.3M | $0 | $0 |
| Other financing | −$9.3M | −$3.2M | $0 | −$4.4M | −$14.1M | −$8.6M | −$138.8M | −$526.4M | −$5.5M | $6.3M |
| Cash from financing activities | −$71.9M | $14.3M | −$231.4M | $238.3M | −$138.6M | −$76.5M | $278.2M | $667.1M | $770.9M | $167.5M |
| Summary | ||||||||||
| Net change in cash | −$40.2M | −$13.4M | −$13.2M | −$77.9M | $121.9M | $12.9M | $35.6M | −$107.6M | $74.2M | $66.7M |
| Cash at end of period | $58.9M | $99.1M | $112.5M | $125.7M | $203.6M | $81.7M | $68.8M | $33.3M | $140.9M | $66.7M |
| Free cash flow | $29.5M | $112.6M | $125.9M | −$316.8M | $265.6M | $89.4M | −$242.8M | −$774.2M | −$697.4M | −$100.8M |
| Free cash flow margin | 12.3% | 52.9% | 57.7% | −271.9% | 214.1% | 642.8% | −256.3% | −1,052.0% | −2,845.4% | −4,760.7% |
| Capex / revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating cash flow / net income | 0.30 | 0.94 | 1.02 | −3.00 | 2.22 | 10.80 | −2.48 | −29.06 | −36.13 | −165.47 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$2.8M | $3.4M | $27.8M | $18.7M | $23.7M | $28.5M | $22.1M | $33.1M | $29.1M | $35.1M | $31.1M | $33.9M |
| Depreciation & amortization | — | $1.5M | $1.4M | $1.4M | — | −$405,000 | — | −$281,000 | $161,000 | −$576,000 | $3.5M | $163,000 |
| Change in working capital | −$15.1M | −$5.5M | $3.6M | −$7.5M | −$1.3M | $16.9M | −$2.7M | −$831,000 | −$3.2M | $9.7M | $10.5M | $2.6M |
| Other non-cash items | $29.6M | $27.3M | −$5.6M | −$3.6M | $5.5M | $1.2M | −$14.7M | $1.2M | $3.9M | $582,000 | −$20.3M | $85.7M |
| Cash from operating activities | $11.8M | $26.6M | $27.2M | $9.0M | $27.9M | $46.2M | $4.7M | $33.1M | $30.0M | $44.8M | $24.7M | $122.3M |
| Investing activities | ||||||||||||
| Capital expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions & other investing | $59.0M | $4.1M | $24.5M | −$41.0M | −$27.3M | −$53.5M | −$24.7M | −$169.0M | $162.4M | −$108.5M | $124.0M | $84.6M |
| Cash from investing activities | $59.0M | $4.1M | $24.5M | −$41.0M | −$27.3M | −$53.5M | −$24.7M | −$169.0M | $162.4M | −$108.5M | $124.0M | $84.6M |
| Financing activities | ||||||||||||
| Dividends paid | −$27.2M | −$37.0M | −$29.2M | −$29.2M | −$29.2M | −$58.2M | −$29.1M | −$29.1M | −$29.1M | −$27.1M | −$27.1M | −$24.5M |
| Share repurchases & issuance (net) | — | — | — | — | — | $924,000 | — | — | — | — | — | — |
| Net borrowing (repayment) | $54.0M | −$6.0M | −$25.6M | −$66.9M | $107.0M | $63.3M | $89.0M | $126.0M | — | — | — | −$120.0M |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $5.5M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | −$2,000 | −$8.3M | $0 | −$785,000 | $0 | −$9.5M | $0 | $0 | −$187.5M | $101.0M | −$115.0M | $0 |
| Cash from financing activities | $26.8M | −$51.3M | −$54.8M | −$96.9M | $77.8M | $2.0M | $59.9M | $96.9M | −$216.5M | $73.9M | −$142.1M | −$144.5M |
| Summary | ||||||||||||
| Net change in cash | $96.4M | −$24.7M | −$27.9M | −$87.7M | $80.5M | −$5.1M | $39.3M | −$38.4M | −$24.4M | $10.0M | $7.1M | −$23.2M |
| Cash at end of period | $130.6M | $34.2M | $58.9M | $86.8M | $174.5M | $94.0M | $99.1M | $59.8M | $98.1M | $122.5M | $112.5M | $105.4M |
| Free cash flow | $11.8M | $26.6M | $27.2M | $9.0M | $27.9M | $46.2M | $4.7M | $33.1M | $30.0M | $44.8M | $24.7M | $122.3M |
| Free cash flow margin | 26.0% | 49.7% | 53.2% | 21.1% | 56.5% | 88.9% | 9.7% | 59.5% | 58.2% | 77.8% | 45.1% | 209.3% |
| Capex / revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating cash flow / net income | — | 7.86 | 0.98 | 0.48 | 1.18 | 1.62 | 0.21 | 1.00 | 1.03 | 1.28 | 0.80 | 3.61 |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
BCSF cash generation
In fiscal 2025 (ended December 31, 2025), Bain Capital Specialty Finance generated $29.5 million of cash from operations (down 73.8%) and spent $0 on capital expenditures, leaving free cash flow of $29.5 million, 12.3% of revenue. It returned $145.8 million to shareholders through dividends ($145.8 million) and net share buybacks ($0). Cash and equivalents fell by $40.2 million over the year.
Related: BCSF income statement, BCSF balance sheet, BCSF dividend history. See the BCSF stock overview for the latest quote and news.
BCSF cash flow FAQ
What is Bain Capital Specialty Finance's free cash flow?
Bain Capital Specialty Finance's free cash flow was $29.5 million in fiscal 2025: $29.5 million of operating cash flow minus $0 of capital expenditures It was $112.6 million a year earlier..
How much cash does Bain Capital Specialty Finance generate from operations?
Bain Capital Specialty Finance generated $29.5 million of cash from operating activities in fiscal 2025, 0.30 times its net income of $98.8 million.
How much does Bain Capital Specialty Finance pay in dividends?
Bain Capital Specialty Finance paid $145.8 million in dividends in fiscal 2025, 493.9% of free cash flow.